National Institute on Alcohol Abuse and Alcoholism (NIAAA)

niaaa.nih.gov

Total trials

102

Active

17

Phase 3

3

Total enrollment

66,668

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 9 of 9 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Acamprosate calcium1
Tirzepatide2
Suvorexant1
Apremilast1
Alcohol3
Ethanol3
[11C]raclopride plus drug2
[11C]NNC-1122
Alirocumab1

Next readouts

  • 2026-07-30
  • 2026-12-31
  • 2026-12-31
  • 2026-12-31
  • 2027-01-31
  • 2027-12-31
  • 2028-12-31
  • 2031-12-31

Top conditions

  • Alcoholism39
  • Alcohol Dependence19
  • Alcohol Use Disorder14
  • Alcohol Drinking12
  • Healthy7
  • Alcohol-Related Disorders7
  • Normal Physiology6
  • Alcohol Abuse5

Frequently asked questions about National Institute on Alcohol Abuse and Alcoholism (NIAAA)

How many clinical trials does National Institute on Alcohol Abuse and Alcoholism (NIAAA) have on ClinicalTrials.gov?
National Institute on Alcohol Abuse and Alcoholism (NIAAA) is listed as the lead sponsor on 102 clinical trials in ClinicalTrials.gov, 17 of which are currently active (recruiting, enrolling, or ongoing).
How many of National Institute on Alcohol Abuse and Alcoholism (NIAAA)'s trials are in Phase 3?
3 of National Institute on Alcohol Abuse and Alcoholism (NIAAA)'s trials are in Phase 3, spread across 9 active drug programs.
What therapeutic areas does National Institute on Alcohol Abuse and Alcoholism (NIAAA) focus on?
National Institute on Alcohol Abuse and Alcoholism (NIAAA)'s most-studied conditions on ClinicalTrials.gov are Alcoholism, Alcohol Dependence, Alcohol Use Disorder, Alcohol Drinking, Healthy.
When are National Institute on Alcohol Abuse and Alcoholism (NIAAA)'s next clinical trial readouts?
National Institute on Alcohol Abuse and Alcoholism (NIAAA) has 8 upcoming primary-completion readouts tracked here; the soonest is “Tirzepatide in MetALD”, expected around 2026-07-30.